3
Total investments
2
Early stage
1
Mid stage
0
Late stage
12y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Dec 2021
Sapient is a biomarker discovery organization providing bespoke services for metabolomics, lipidomics, and proteomics data generation and analysis, enabling biopharma sponsors to go beyond the genome to accelerate precision drug development.
Using state-of-the-art, high-throughput mass spectrometry technologies, Sapient enables nontargeted multi-omics measurements to capture thousands of dynamic biomarkers – including metabolites, lipids, and proteins – across thousands of samples at a time.
These technologies are leveraged within a larger discovery infrastructure that includes a comprehensive biocomputational framework for analysis of large-scale, multi-omics data; robust quality control analysis; and mapping of key biomarker-phenotype associations. Sapient can cross-validate discoveries using our proprietary in-house longitudinal Human Biology Database that includes data from over 100,000 human biosamples with paired phenotypic measures.
Together our approaches enable rapid identification, validation, and translation of dynamic biomarkers of biological processes, disease mechanisms, and drug response across all drug development phases.
Angel Investor
Dec 2018
Terray is a biotechnology company with the technology, data, and mindset to radically change the way we discover and develop small molecule therapeutics. We explore molecules and targets broadly and deeply with a sophisticated integration of ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology. Everything the company does is grounded in an iterative approach, producing massive amounts of precise, purpose-built data that gets increasingly valuable with each cycle of design and experimentation. The company’s platform uniquely blends experimentation and computation to improve the cost, speed, and success rate of small molecule drug discovery and development.
Angel Investor
Jun 2014
Reviver is a technology company and developer of the first-of-its-kind digital license plate platform. We are on a mission to modernize the driving experience. Our team is transforming the license plate into a platform for connected vehicles through the RPlate, the first digital license plate, enables mobile registration renewal, personalization, location and safety features, and more. The RPlate is now DMV-approved for use on consumer and commercial vehicles.
Experience · 5 entries
All (5)
Investments (3)
Board (1)
2021
Board Member
Dec 2021
Sapient is a biomarker discovery organization providing bespoke services for metabolomics, lipidomics, and proteomics data generation and analysis, enabling biopharma sponsors to go beyond the genome to accelerate precision drug development.
Using state-of-the-art, high-throughput mass spectrometry technologies, Sapient enables nontargeted multi-omics measurements to capture thousands of dynamic biomarkers – including metabolites, lipids, and proteins – across thousands of samples at a time.
These technologies are leveraged within a larger discovery infrastructure that includes a comprehensive biocomputational framework for analysis of large-scale, multi-omics data; robust quality control analysis; and mapping of key biomarker-phenotype associations. Sapient can cross-validate discoveries using our proprietary in-house longitudinal Human Biology Database that includes data from over 100,000 human biosamples with paired phenotypic measures.
Together our approaches enable rapid identification, validation, and translation of dynamic biomarkers of biological processes, disease mechanisms, and drug response across all drug development phases.
2018
Angel Investor
Dec 2018
Terray is a biotechnology company with the technology, data, and mindset to radically change the way we discover and develop small molecule therapeutics. We explore molecules and targets broadly and deeply with a sophisticated integration of ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology. Everything the company does is grounded in an iterative approach, producing massive amounts of precise, purpose-built data that gets increasingly valuable with each cycle of design and experimentation. The company’s platform uniquely blends experimentation and computation to improve the cost, speed, and success rate of small molecule drug discovery and development.
2014
Angel Investor
Jun 2014
Reviver is a technology company and developer of the first-of-its-kind digital license plate platform. We are on a mission to modernize the driving experience. Our team is transforming the license plate into a platform for connected vehicles through the RPlate, the first digital license plate, enables mobile registration renewal, personalization, location and safety features, and more. The RPlate is now DMV-approved for use on consumer and commercial vehicles.
2008
Associate Sales Engineer
Jul 2008
Parker Hannifin is a Fortune 250 global leader in motion and control technologies. For more than a century the company has been enabling engineering breakthroughs that lead to a better tomorrow. Learn more at www.parker.com or on Twitter @parkerhannifin.
Executive Officers:
Jennifer A. Parmentier, Chairman of the Board and Chief Executive Officer
Andrew D. Ross, President and Chief Operating Officer
Todd Leombruno, Executive Vice President and Chief Financial Officer
Mark J. Hart, Executive Vice President, Human Resources and External Affairs
See our complete Global Leadership Team - https://www.parker.com/us/en/about-parker/parker-leadership.html
Visit our Parker Technology Blog at http://blog.parker.com
Follow us:
X at http://twitter.com/parkerhannifin
Facebook at http://facebook.com/parkerhannifin
YouTube channel http://youtube.com/parkervideo
Youtube Product and support channel: https://www.youtube.com/@ParkerProductsSupport
Instagram - http://instagram.com/parkerhannifin
The companys products are vital to virtually everything that moves or requires control, including the manufacture and processing of raw materials, durable goods, infrastructure development and all forms of transport. Key technology areas are aerospace, climate control, electromechanical, filtration, fluid and gas handling, hydraulics, pneumatics, process control, sealing and shielding and human motion. Traded on the New York Stock Exchange under the symbol "PH," Parker is strategically diversified, value-driven and well positioned for global growth as the industry consolidator and supplier of choice.
Interested in a career at Parker Hannifin:
Website at www.parker.com/careers
2005
User Experience Associate
Jul 2005
Lutech CDM leads its clients on the path of digital transformation, helping companies to adopt innovative technologies capable of increasing the interconnection and collaboration of resources used in operational processes, to create value and business opportunities. Application skills in different business areas and project implementation experience are a key competitive advantage and add real value to our offering.
Since 1986, Lutech CDM has been providing solutions and services to manage, optimise and support the information systems of companies operating in global markets, from both an infrastructure and an application perspective, ensuring the agility and dynamism required in todays ever-changing business environment.
From 2018 Lutech CDM is part of the Lutech group, a leader in innovation (among the top three in Italy), with 4,700 employees and revenues of about 800 million euros, supporting the transformation and growth of companies and institutions. The group designs, implements and manages end-to-end solutions under the banner of constant improvement involving people and processes, technology and knowledge.
Investment activity
2014–2021 · 3 investments
Recent (last 2 years)Earlier